Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$1.73B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$635M |
| 3 |
Bank of America
BAC
|
+$611M |
| 4 |
Meta Platforms (Facebook)
META
|
+$574M |
| 5 |
Warner Bros
WBD
|
+$513M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$4.89B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$1.03B |
| 4 |
CYBR
CyberArk
CYBR
|
+$913M |
| 5 |
NVIDIA
NVDA
|
+$853M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.09% |
| 2 | Financials | 7.06% |
| 3 | Industrials | 6.02% |
| 4 | Healthcare | 5.98% |
| 5 | Consumer Discretionary | 4.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
ImmunityBio
IBRX
$7.8B
| $10.9M | ﹤0.01% |
1,420,244
+1,301,816
| +1,099% | +$8.91M |
|
2027
Cathay General Bancorp
CATY
$4.21B
| $10.9M | ﹤0.01% |
218,006
-43,924
| -17% | -$2.22M |
|
2028
Capricor Therapeutics
CAPR
$243M
| $10.8M | ﹤0.01% |
356,354
-325,990
| -48% | -$8.69M |
|
2029
CALL
Clorox
CLX
$11.7B
| $10.8M | ﹤0.01% |
104,500
+47,200
| +82% | +$5.35M |
|
2030
Ambev
ABEV
$48.2B
| $10.8M | ﹤0.01% |
3,706,523
+1,396,966
| +60% | +$3.99M |
|
2031
CALL
PNC Financial Services
PNC
$99.2B
| $10.8M | ﹤0.01% |
52,000
-6,700
| -11% | -$1.46M |
|
2032
Edgewise Therapeutics
EWTX
$4.42B
| $10.8M | ﹤0.01% |
342,867
+216,431
| +171% | +$6.24M |
|
2033
Bank of N.T. Butterfield & Son
NTB
$2.45B
| $10.8M | ﹤0.01% |
205,784
-150,264
| -42% | -$7.71M |
|
2034
Commercial Metals
CMC
$7.57B
| $10.8M | ﹤0.01% |
175,798
-1,197,619
| -87% | -$86.5M |
|
|
SNCY
2035
DELISTED
Sun Country Airlines
SNCY
| $10.8M | ﹤0.01% |
+652,924
| New | +$11.7M |
|
2036
CALL
Abbott
ABT
$183B
| $10.8M | ﹤0.01% |
105,000
-477,700
| -82% | -$53.9M |
|
2037
Knife River
KNF
$4.15B
| $10.8M | ﹤0.01% |
131,811
+107,327
| +438% | +$8.65M |
|
|
KLAR
2038
Klarna Group
KLAR
$7.18B
| $10.8M | ﹤0.01% |
821,906
+377,783
| +85% | +$7.48M |
|
2039
Carter's
CRI
$1.39B
| $10.8M | ﹤0.01% |
300,810
-401,545
| -57% | -$14.6M |
|
2040
PUT
GE HealthCare
GEHC
$31.6B
| $10.7M | ﹤0.01% |
151,000
-2,600
| -2% | -$205K |
|
2041
Turning Point Brands
TPB
$1.47B
| $10.7M | ﹤0.01% |
123,817
+120,068
| +3,203% | +$13.4M |
|
2042
MoonLake Immunotherapeutics
MLTX
$1.62B
| $10.7M | ﹤0.01% |
576,092
-226,630
| -28% | -$3.75M |
|
2043
SunCoke Energy
SXC
$717M
| $10.7M | ﹤0.01% |
1,648,849
-51,107
| -3% | -$362K |
|
|
THR
2044
DELISTED
Thermon Group Holdings
THR
| $10.7M | ﹤0.01% |
212,505
+192,677
| +972% | +$8.98M |
|
2045
PUT
Wingstop
WING
$3.66B
| $10.7M | ﹤0.01% |
69,100
+23,100
| +50% | +$5.55M |
|
2046
Cognex
CGNX
$10.4B
| $10.7M | ﹤0.01% |
218,455
-36,586
| -14% | -$1.71M |
|
2047
CALL
D.R. Horton
DHI
$40.7B
| $10.7M | ﹤0.01% |
77,900
-60,100
| -44% | -$9.08M |
|
2048
OneSpan
OSPN
$571M
| $10.6M | ﹤0.01% |
1,009,376
-202,283
| -17% | -$2.29M |
|
2049
Maplebear
CART
$10.5B
| $10.6M | ﹤0.01% |
283,589
+26,564
| +10% | +$1.01M |
|
2050
PUT
GSK
GSK
$104B
| $10.6M | ﹤0.01% |
+191,900
| New | +$10.4M |
|
Similar funds
Millennium Management's Q1 2026 Portfolio in Review
As of Q1 2026, Millennium Management held 6,611 positions worth $240B, up 1.1% from $238B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Millennium Management's Q1 2026 filing shows 658 new, 2,264 increased, 2,324 reduced and 989 closed positions. Its largest new stake was State Street SPDR Portfolio S&P 500 ETF: 21,566,182 shares worth $1.65B. The largest sale was Walmart Inc, an estimated $4.89B.
By sector, the portfolio is most concentrated in Technology at 9.1% of assets, down from 9.5% a quarter earlier, followed by Financials and Industrials.
- Millennium Management's largest Q1 2026 buy was State Street SPDR Portfolio S&P 500 ETF: 21,566,182 shares worth $1.65B.
- Millennium Management added most to Vanguard S&P 500 ETF in Q1 2026, an estimated $635M increase.
- Millennium Management's biggest Q1 2026 reduction was Walmart Inc, cutting an estimated $4.89B.
- Millennium Management fully exited CyberArk in Q1 2026, selling an estimated $913M.
- Millennium Management's ten largest holdings make up 17% of its $240B portfolio in Q1 2026.
- Millennium Management opened 658 new positions and closed 989 in Q1 2026.
- Millennium Management's portfolio value rose 1.1% quarter-over-quarter to $240B.
Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.